Home R&D Page 2

R&D

New COVID-19 drug ready for human testing
Featured

New COVID-19 drug ready for human testing

Dominic Cuthbert -
0
Avacta develops SARS-COV-2 neutralising Affimer reagents with therapeutic potential for COVID-19
Featured

Avacta develops SARS-COV-2 neutralising Affimer reagents with therapeutic potential for COVID-19

Tess Egginton -
0
Acer & NCATS to develop emetine as potential COVID-19 treatment
Featured

Acer & NCATS to develop emetine as potential COVID-19 treatment

Dominic Cuthbert -
0
Tonix and Alberta Uni to develop novel horsepox-based vaccines for COVID-19
Featured

Tonix and Alberta Uni to develop novel horsepox-based vaccines for COVID-19

Dominic Cuthbert -
0
Lilly & Junshi Biosciences to co-develop antibody therapies for COVID-19
Featured

Lilly & Junshi Biosciences to co-develop antibody therapies for COVID-19

Dominic Cuthbert -
0
AstraZeneca & Oxford University partner for COVID-19 vaccine
Featured

AstraZeneca & Oxford University partner for COVID-19 vaccine

Dominic Cuthbert -
0
Encouraging remdesivir results demonstrate accelerate recovery in COVID-19
Featured

Encouraging remdesivir results demonstrate accelerate recovery in COVID-19

Dominic Cuthbert -
0
Antibody discovery agreement to support development of new therapeutics for acute and chronic inflammatory syndromes
R&D

Antibody discovery agreement to support development of new therapeutics for acute and chronic inflammatory syndromes

Tess Egginton -
0
Shionogi steps up development of potential COVID-19 treatments & vaccine
Featured

Shionogi steps up development of potential COVID-19 treatments & vaccine

Dominic Cuthbert -
0
Merck & ISB team up to define molecular mechanism of SARS-CoV-2
Featured

Merck & ISB team up to define molecular mechanism of SARS-CoV-2

Dominic Cuthbert -
0
123...168Page 2 of 168

© 2020 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks